Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 271–285 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2897 FGFR2 Gene (Crouzon Syndrome) Genetic Test This test evaluates the FGFR2 gene for pathogenic variants associated with Crouzon syndrome.	Peripheral Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FGFR2 gene", "Single nucleotide variants", "Small insertions/deletions"] Parameters [] Preparation [] Indications ["Definitive diagnosis of Crouzon syndrome", "Differential exclusion of other craniosynostosis syndromes", "Informed family planning"] Measurement technique Confirm with laboratory Codes LOINC: 93296-0 ICD-10: Q87.0 Clinical summary This test evaluates the FGFR2 gene for pathogenic variants associated with Crouzon syndrome.
TEST-2701 FGFR2 Gene Analysis for Jackson-Weiss Syndrome (Genetic Test) This test identifies pathogenic variants within the FGFR2 gene associated with Jackson-Weiss syndrome.	Peripheral Whole Blood or Extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in FGFR2 gene", "Coding exons and flanking splice regions"] Parameters [] Preparation ["No fasting required", "No medication changes needed for blood draw"] Indications ["Suspected Jackson-Weiss syndrome", "Family history of craniosynostosis-syndactyly disorders", "Need for genetic confirmation for surgical planning", "Recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 91576-0 ICD-10: Q87.0 Clinical summary This test identifies pathogenic variants within the FGFR2 gene associated with Jackson-Weiss syndrome.
TEST-3077 FGFR2 Gene Apert Syndrome Genetic Test This test identifies pathogenic and likely pathogenic variants in the FGFR2 gene to confirm a diagnosis of Apert syndrome and related craniosynostosis disorders.	Peripheral whole blood (EDTA tube, 3–5 mL), extracted DNA, or FTA card blood spot	3–4 weeks from sample receipt at laboratory	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FGFR2 gene sequence variants", "FGFR2 gene copy number variations"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Suspected Apert syndrome", "Suspected Crouzon syndrome", "Suspected Pfeiffer syndrome", "Other FGFR2-related craniosynostosis disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21636-1 ICD-10: Q87.0 Clinical summary This test identifies pathogenic and likely pathogenic variants in the FGFR2 gene to confirm a diagnosis of Apert syndrome and related craniosynostosis disorders.
TEST-5316 FGFR2 Gene Beare‑Stevenson Cutis Gyrata Syndrome Genetic Test This genetic test identifies pathogenic variants in the FGFR2 gene associated with Beare‑Stevenson cutis gyrata syndrome.	Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3–4 Weeks (21–28 calendar days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FGFR2 gene"] Parameters [] Preparation ["No special preparation such as fasting is required.", "Inform the phlebotomist of any anticoagulant medications or bleeding disorders."] Indications ["Suspected Beare‑Stevenson cutis gyrata syndrome", "Differential diagnosis of FGFR‑related craniosynostosis syndromes"] Measurement technique Confirm with laboratory Codes LOINC: 82757-6 ICD-10: Q87.8 Clinical summary This genetic test identifies pathogenic variants in the FGFR2 gene associated with Beare‑Stevenson cutis gyrata syndrome.
TEST-5498 FGFR3 Gene Achondroplasia Genetic Test This test identifies pathogenic variants in the FGFR3 gene associated with achondroplasia.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FGFR3 gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No special preparation required", "Test performed on peripheral whole blood"] Indications ["Diagnosis of achondroplasia", "Family planning for individuals with achondroplasia", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 92720-5 ICD-10: Q77.4 Clinical summary This test identifies pathogenic variants in the FGFR3 gene associated with achondroplasia.
TEST-5248 FGFR3 Gene Crouzon Syndrome with Acanthosis Nigricans Genetic Test This test identifies pathogenic variants in the FGFR3 gene associated with Crouzon syndrome with acanthosis nigricans.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FGFR3 gene", "Single-nucleotide variants", "Small insertions/deletions", "Copy number changes"] Parameters [] Preparation ["No fasting required.", "No medication adjustments required.", "Hydrate well.", "Provide detailed personal/family medical history."] Indications ["Suspected Crouzon syndrome with acanthosis nigricans", "Definitive molecular diagnosis", "Informed clinical management"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.0, L83 Clinical summary This test identifies pathogenic variants in the FGFR3 gene associated with Crouzon syndrome with acanthosis nigricans.
TEST-4593 FGFRL1 Gene Radioulnar Synostosis Genetic Test This genetic test evaluates the FGFRL1 gene for pathogenic variants associated with radioulnar synostosis and related phenotypes.	Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in FGFRL1 gene", "Single-nucleotide variants", "Small insertions/deletions", "Copy-number changes"] Parameters [] Preparation ["No specific fasting required", "Avoid acute febrile illness or active systemic infection before blood collection"] Indications ["Suspected radioulnar synostosis", "Diagnosis of related skeletal, dermatological, or immunological phenotypes", "Family history of FGFRL1-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 94222-3 ICD-10: Q74.0 Clinical summary This genetic test evaluates the FGFRL1 gene for pathogenic variants associated with radioulnar synostosis and related phenotypes.
TEST-5215 Filaggrin (FLG) Gene Atopic Dermatitis Type 2 Genetic Test This genetic test evaluates the FLG gene for mutations associated with atopic dermatitis and related skin barrier disorders.	Peripheral whole blood (EDTA) or buccal swab	14–21 working days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FLG gene mutations", "Skin barrier integrity"] Parameters [] Preparation [] Indications ["Diagnosis confirmation of atopic dermatitis", "Risk stratification for atopic dermatitis", "Guiding targeted therapies"] Measurement technique Confirm with laboratory Codes LOINC: 83263-0 ICD-10: L20.9, L20.8 Clinical summary This genetic test evaluates the FLG gene for mutations associated with atopic dermatitis and related skin barrier disorders.
TEST-5148 FKRP Gene (Muscular Dystrophy Type 1C) NGS Test This diagnostic test evaluates the FKRP gene for pathogenic variants associated with congenital muscular dystrophy type 1C (MDC1C) and limb-girdle muscular dystrophy 2I (LGMD2I).	Peripheral whole blood (3–5 mL in EDTA tube)	3–4 weeks (21–28 days) from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FKRP gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed"] Indications ["Suspected congenital muscular dystrophy type 1C (MDC1C)", "Suspected limb-girdle muscular dystrophy 2I (LGMD2I)", "Family history of FKRP-related muscular dystrophy"] Measurement technique Confirm with laboratory Codes LOINC: 94268-2 ICD-10: G71.0 Clinical summary This diagnostic test evaluates the FKRP gene for pathogenic variants associated with congenital muscular dystrophy type 1C (MDC1C) and limb-girdle muscular dystrophy 2I (LGMD2I).
TEST-4371 FLNA Gene Cardiac Valvular Dysplasia, X-Linked Genetic Test This test evaluates the FLNA gene for pathogenic variants associated with X-linked cardiac valvular dysplasia.	Peripheral whole blood (3–5 mL in EDTA lavender-top tube)	3 to 4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FLNA gene variants (SNVs, indels, CNVs)", "Pathogenic and likely pathogenic variants"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Diagnosis of X-linked cardiac valvular dysplasia", "Cascade screening of at-risk family members", "Risk stratification for individuals with suspected FLNA-related heart conditions"] Measurement technique Confirm with laboratory Codes LOINC: 82993-5 ICD-10: Q24.8 Clinical summary This test evaluates the FLNA gene for pathogenic variants associated with X-linked cardiac valvular dysplasia.
TEST-4642 FLNA Gene Neuronal Intestinal Pseudo-obstruction Genetic Test This genetic test identifies pathogenic variants in the FLNA gene, which are associated with neuronal intestinal pseudo-obstruction.	Peripheral whole blood (EDTA) or DNA FTA card	3 – 4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FLNA gene pathogenic variants", "Copy Number Variants (CNVs) in FLNA"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed"] Indications ["Clinical suspicion of neuronal intestinal pseudo-obstruction", "Family history of FLNA-related disorders", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 101411-5 ICD-10: K59.8, Q04.5, Z13.79 Clinical summary This genetic test identifies pathogenic variants in the FLNA gene, which are associated with neuronal intestinal pseudo-obstruction.
TEST-5391 FLNB Gene Atelosteogenesis Type 1 Genetic Test This test identifies pathogenic variants in the FLNB gene associated with Atelosteogenesis Type 1 (AO1), a severe skeletal dysplasia.	Whole Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FLNB gene variants", "Single nucleotide variants", "Small indels", "Copy number variations"] Parameters [] Preparation ["Mandatory pre-test genetic counseling session."] Indications ["Neonatal diagnosis of skeletal dysplasia", "Carrier screening", "Familial variant tracking", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q77.3 Clinical summary This test identifies pathogenic variants in the FLNB gene associated with Atelosteogenesis Type 1 (AO1), a severe skeletal dysplasia.
TEST-5252 FLNC Gene Distal Myopathy Type 4 Genetic Test This genetic test evaluates the FLNC gene for pathogenic mutations associated with distal myopathy type 4.	Peripheral Whole Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic FLNC gene mutations", "Copy number variants in FLNC gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Suspected distal myopathy type 4", "Family history of distal myopathy", "Screening of at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 81268-8 ICD-10: G71.0 Clinical summary This genetic test evaluates the FLNC gene for pathogenic mutations associated with distal myopathy type 4.
TEST-4828 FLT4 Gene Hereditary Lymphedema Type 1A Genetic Test This test evaluates the FLT4 gene for pathogenic variants associated with Hereditary Lymphedema Type 1A (Milroy disease).	Peripheral Whole Blood (FTA Card also accepted)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FLT4 gene", "Single nucleotide variants", "Small indels", "Copy number variations"] Parameters [{"name": "Detection & Sensitivity", "reference_range": "99.9% – includes CNVs, deep intronic variants"}] Preparation ["No specific fasting required", "Genetic counselling is mandatory prior to testing", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Diagnosis of Hereditary Lymphedema Type 1A (Milroy disease)", "Genetic counselling for families with lymphedema"] Measurement technique Confirm with laboratory Codes LOINC: 104197-1 ICD-10: Q82.0 Clinical summary This test evaluates the FLT4 gene for pathogenic variants associated with Hereditary Lymphedema Type 1A (Milroy disease).
TEST-2278 FOXP2 Gene Speech-Language Disorder Type 1 Genetic Test This genetic test identifies pathogenic variants in the FOXP2 gene associated with Childhood Apraxia of Speech (CAS) and related dysmorphology.	Whole Blood (EDTA) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FOXP2 gene", "Coding regions and splice sites of the FOXP2 gene"] Parameters [] Preparation [] Indications ["Suspected Childhood Apraxia of Speech (CAS)", "Family history of FOXP2-related disorders", "Need for personalized speech therapy"] Measurement technique Confirm with laboratory Codes LOINC: 92121-8 ICD-10: F80.81, Z13.89 Clinical summary This genetic test identifies pathogenic variants in the FOXP2 gene associated with Childhood Apraxia of Speech (CAS) and related dysmorphology.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.